Zoetis Inc. Other Accrued Liabilities, Noncurrent
Zoetis Inc. (ZTS) had Other Accrued Liabilities, Noncurrent of $451.00 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Notes
us-gaap:OtherAccruedLiabilitiesNoncurrent · last filed 2019-11-07
- 2019-09-30: Other Accrued Liabilities, Noncurrent $451.00M.
- 2019-06-30: Other Accrued Liabilities, Noncurrent $443.00M.
- 2019-03-31: Other Accrued Liabilities, Noncurrent $448.00M.
- 2018-12-31: Other Accrued Liabilities, Noncurrent $487.00M.
| Period end | Other Accrued Liabilities, Noncurrent |
|---|---|
| 2019-09-30 | $451.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $443.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $448.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $487.00M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $425.00M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $434.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $419.00M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $432.00M 10-Q · filed 2018-11-01 |
| 2017-10-01 | $413.00M 10-Q · filed 2017-11-02 |
| 2017-07-02 | $406.00M 10-Q · filed 2017-08-08 |
| 2017-04-02 | $383.00M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $464.00M 10-Q · filed 2017-11-02 |
| 2016-10-02 | $457.00M 10-Q · filed 2016-11-03 |
| 2016-07-03 | $512.00M 10-Q · filed 2016-08-05 |
| 2016-04-03 | $552.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $676.00M 10-Q · filed 2016-11-03 |
| 2015-09-27 | $599.00M 10-Q · filed 2015-11-05 |
| 2015-06-28 | $627.00M 10-Q · filed 2015-08-06 |
| 2015-03-29 | $426.00M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $475.00M 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |